Sign in

You're signed outSign in or to get full access.

Michael Bless

Director at Enact Holdings
Board

About Michael A. Bless

Michael A. Bless, age 59, is an independent director of Enact Holdings (ACT) who joined the Board in March 2022. He chairs the Independent Capital Committee and serves on the Risk Committee. Bless is the former CEO of Century Aluminum and previously held CFO roles at Century Aluminum, Maxtor, and Rockwell Automation; he began his career in investment banking at Dillon, Read. He holds an A.B. in History from Princeton University . The Board has determined he meets Nasdaq independence requirements .

Past Roles

OrganizationRoleTenureCommittees/Impact
Century Aluminum Company (CENX)President & CEO; DirectorCEO Nov 2011–Jul 2021; Director Dec 2012–Jul 2021Led primary aluminum producer; prior EVP & CFO (2006–Nov 2011)
M. Safra & Co., Inc.Investment professional2005–2006Investment role at private firm
Maxtor Corporation (MXO)Chief Financial Officer2004Public company CFO experience
Rockwell Automation (ROK)Chief Financial Officer; other leadership roles2001–2004 (CFO); prior leadership roles earlierCorporate finance and operations leadership
Dillon, Read & Co. Inc.Investment banker1987–1997Corporate finance and capital markets foundation

External Roles

CompanyRoleTenureCommittees/Positions
CNA Financial (CNA)Independent DirectorSince 2017Chair, Compensation Committee; Member, Audit and Finance Committees
Piedmont Lithium (PLL)Independent DirectorSince Jan 2023Member, Audit; Member, Leadership & Compensation Committees
Simpson Manufacturing (SSD)Independent Director (prior)2017–2021Former director

Board Governance

  • Committee assignments: Chair, Independent Capital Committee (ICC); Member, Risk Committee .
  • ICC scope and authority: Provides independent oversight of capital actions (debt/equity issuance, dividends/buybacks, capital contributions to subs other than EMICO); reviews and can veto specified actions referred by the Board, and any ICC veto cannot be overturned by the Board. ICC is maintained so long as Genworth owns ≥50% voting power and there are minority public stockholders .
  • Risk Committee scope: Oversees enterprise risk (credit, market, insurance, housing, operational, model, IT, climate, investment, AI, cybersecurity). Majority independent; independence requirement applies fully when Enact is no longer a controlled company .
  • 2024 meetings: Board met 9 times; each nominee (including Bless) attended >75% of combined Board and committee meetings; all directors attended the 2024 annual meeting .
  • Independence: Enact qualifies as a “controlled company” due to Genworth’s majority voting power, but the Board determined Bless is independent under Nasdaq rules .
  • Committee independence context: Three Board committees are 100% independent and the rest are majority independent; all committees have independent chairpersons .
  • Overboarding policy: Non-CEO directors should not serve on more than four other public boards; CEO-equivalent directors on no more than two other public boards; Enact currently has an independent Board Chair and no Lead Director .

Fixed Compensation

Program Element (2024)Cash ($)DSUs ($)Notes
Annual Retainer (Independent Director)110,000160,000DSUs granted following annual meeting; cash paid quarterly
Additional Retainer – Board Chair80,000120,000Not applicable to Bless
Additional Retainer – Committee Chair20,000“Other committees” chairs receive $20k cash (ICC qualifies)
Additional Retainer – Audit Chair35,000Not applicable to Bless
Meeting FeesNot disclosed; program based on retainers and DSUs
Charitable Match (max)Up to $10,000 matched via Enact Foundation
2024 Director Compensation – Michael A. BlessAmount ($)
Fees Earned or Paid in Cash130,000
Stock Awards (DSUs, grant-date fair value)158,905
Other Compensation
Total288,905

Structure signposts: Cash retainer plus ICC chair fee reconcile to Bless’s $130,000 cash (=$110,000 base + $20,000 committee chair), with annual DSU grant ~$160,000 (actual $158,905) .

Performance Compensation

Equity Award FeatureDetails
VehicleDeferred Stock Units (DSUs) granted annually under the 2021 Plan
Grant sizingNumber of DSUs = target value ($160,000) ÷ FMV on grant date
DividendsDSUs accrue regular quarterly dividends, reinvested in DSUs
SettlementSettled 1 year after director leaves the Board in single lump sum (or upon death); per ownership table footnote, DSUs may alternatively be paid over 10 years at director election
2024 Bless grant value (ASC 718)$158,905

Note: Director equity is service-based DSUs; no performance metrics or PSU/option awards are used for non-management directors .

Other Directorships & Interlocks

External Public CompanyPotential Interlock/Conflict Consideration
CNA Financial (insurance)No related-party transaction disclosures specific to Bless were identified in the retrieved proxy sections; standard Related Person Transaction Policy applies and Audit Committee oversees such reviews .
Piedmont Lithium (materials)As above; no director-specific related transactions identified in retrieved sections .

Expertise & Qualifications

  • Brings >20 years of corporate finance experience, including CFO of three public companies and CEO of Century Aluminum; experienced director at two public companies .
  • Education: A.B. in History, Princeton University .
  • Board-level capital allocation oversight as ICC Chair; risk oversight experience as Risk Committee member .

Equity Ownership

ItemValue
Beneficially owned Enact common shares (as of Mar 19, 2025)5,000 shares
Other stock-based holdings (non-management director DSUs) (as of Mar 19, 2025)21,292 DSUs (settle in stock post-service per footnote)
DSUs held (as of Dec 31, 2024)21,172 DSUs
Shares outstanding (as of Mar 19, 2025)151,391,312 shares
Anti-hedging / Anti-pledgingDirectors prohibited from hedging and pledging Enact securities
Stock ownership guidelines (Directors)Required ≥5x annual cash retainer; compliance expected within 5 years of appointment; all directors are in compliance or on track

DSU settlement mechanics: DSUs settle one year after leaving the Board in a lump sum or may be paid over 10 years at the director’s election (or earlier upon death) .

Governance Assessment

  • Strengths

    • Independent status affirmed; service on ICC (Chair) and Risk enhances minority shareholder protections, especially given controlled company context .
    • ICC veto right over capital actions (issuances, dividends/buybacks, certain capital contributions) is a strong safeguard; Bless’s chair role is a positive signal for capital allocation discipline .
    • Attendance thresholds met (>75% in 2024); Board and all committees have independent chairpersons .
    • Director pay balanced between cash and equity; DSU design aligns with long-term value; anti-hedging/anti-pledging and ownership guidelines further alignment .
  • Watch items / potential red flags

    • Controlled company status: Compensation Committee is not fully independent due to Genworth designee; equity awards for officers and directors are approved by the full Board until all Comp Committee members qualify as “non-employee directors” under Rule 16b-3 .
    • Genworth rights under Master Agreement (committee designation and board sizing constraints) may influence governance dynamics; however, ICC remains fully independent and insulated .
    • External board seats: Bless serves on two other public boards, within Enact’s overboarding policy, but time commitments should continue to be monitored alongside committee chair duties at CNA and ICC responsibilities at Enact .
  • Compensation structure observations

    • Only change in 2024 director program was an increase of Audit Chair cash retainer by $5,000; no broader inflation of director pay .
    • Bless’s 2024 cash fees align with role-based structure (base + ICC chair); equity award consistent with standard $160,000 DSU grant .
  • Related party and conflicts

    • Proxy details policy and oversight but retrieved sections do not identify any Bless-specific related-person transactions; continue to review annual disclosures for updates .